These innovative treatments , including Semaglutide , belong to a class of drugs called GLP-1 agents. Originally intended for managing high blood sugar, they operate by helping the pancreas to produce more insulin and curbing increased glucose levels. Beyond diabetes, their capacity to encourage weight management has led to substantial discussio… Read More